{
  "compound": "THC, CBD, synthetic cannabinoids",
  "condition": "CANCER_PALLIATIVE",
  "effect_size": "N/A (preclinical)",
  "study_type": "MECHANISTIC",
  "source": "NORML:CANCER_MECHANISTIC_001",
  "participants": "Comprehensive preclinical review",
  "year": 2012,
  "notes": "Antitumor Effects of Cannabinoids: Preclinical Evidence Review",
  "confidence": "medium",
  "abstract": "Mechanisms identified: Apoptosis induction, autophagy activation, angiogenesis inhibition, invasion/metastasis reduction; Active in glioma, breast, prostate, lung cancer models"
}